Blackstone Life Sciences clinches royalty deal with Medtronic, Apollo-spinout Nexus Capital targets $1bn-plus for next fund, Kinderhook’s Avita sees big opportunity in pharmacy management

Blackstone invests in Medtronic and Nexus Capital targets $1 billion for new fund.